Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chinese Journal of Natural Medicines is Scopus-indexed (Q1, CiteScore 7.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by China Pharmaceutical University.
Checked against the index lists dated .
ISSN 1875-5364Verify ISSN ↗2095-6975Verify ISSN ↗
Publisher: China Pharmaceutical University
Cost to publish: About US$3,000 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Complementary and Alternative Medicine | 10 / 115 | 91st | Q1 |
| Drug Discovery | 39 / 161 | 76th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q1, CiteScore 7.7.
Chinese Journal of Natural Medicines is Q1 in Complementary and Alternative Medicine (rank 10 of 115) and Q1 in Drug Discovery (rank 39 of 161), by CiteScore 2025.
Chinese Journal of Natural Medicines is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.7, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.096, quartile Q1, with an H-index of 60.
The publisher lists an article processing charge of about US$3,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Chinese Journal of Natural Medicines is published by China Pharmaceutical University. Its print ISSN is 1875-5364 and its online ISSN is 2095-6975.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Chinese Journal of Natural Medicines has an h-index of 60 and a 2-year mean of 4.05 citations per paper (OpenAlex). Its Scopus CiteScore is 7.7, quartile Q1. On 2-year citations it ranks #13 of 109 Scopus journals in Complementary and Alternative Medicine.
Chinese Journal of Natural Medicines published 133 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from China (93%), Macao SAR China (2.5%) and United States (1.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.